[{"AccountsPayableCurrent_0_Q2_USD":2373000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":334000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5064000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":9060000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4851000.0,"ShortTermInvestments_0_Q2_USD":128942000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":123666000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-24000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-231000.0,"DividendsCommonStockCash_2_Q2_USD":0.0,"DeferredCosts_0_Q2_USD":205000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":5350000.0,"InvestmentIncomeInterest_2_Q2_USD":1055000.0,"InvestmentIncomeInterest_1_Q2_USD":266000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":4372000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-24000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-231000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-63912000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-37700000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":576000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-4146000.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1_Q2_USD":0.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_2_Q2_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2005000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":313000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":8724000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4851000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":76528000.0,"RestrictedCashNoncurrent_0_Q2_USD":210000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q2_USD":8404000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":191750000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":133954000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":569000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0716,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1323000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":139000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1680000.0,"OperatingLeaseLiability_0_Q2_USD":1819000.0,"OperatingLeaseCost_2_Q2_USD":681000.0,"OperatingLeaseCost_1_Q2_USD":341000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":64000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":911000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":972000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1883000.0,"LeaseCost_2_Q2_USD":783000.0,"LeaseCost_1_Q2_USD":393000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":7000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":113682000.0,"CashCollateralForBorrowedSecurities_0_Q2_USD":210000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":252398000.0,"VariableLeaseCost_1_Q2_USD":52000.0,"IncomeTaxesPaid_2_Q2_USD":282000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2936000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":57573000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":79975000.0,"LiabilitiesCurrent_0_Q2_USD":20552000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":271441000.0,"Liabilities_0_Q2_USD":21025000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3843000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-3228000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":3696000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":5875000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-60192000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-31594000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":18022000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":9536000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.13,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.65,"Depreciation_2_Q2_USD":1189000.0,"Depreciation_1_Q2_USD":595000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":123456000.0,"AssetsCurrent_0_Q2_USD":264493000.0,"Assets_0_Q2_USD":271441000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":8970107.0,"AdditionalPaidInCapital_0_Q2_USD":670371000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":9000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-61020000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3514000.0,"NetIncomeLoss_1_Q2_USD":-37469000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":223000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0071,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0039,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.7971,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.7938,"ShareBasedCompensation_2_Q2_USD":9060000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":43225000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":22324000.0,"OperatingLossCarryforwards_0_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":-61247000.0,"OperatingIncomeLoss_1_Q2_USD":-31860000.0,"OperatingExpenses_2_Q2_USD":61247000.0,"OperatingExpenses_1_Q2_USD":31860000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q2_pure":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":16499000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":57914105.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":56618397.0,"StockholdersEquity_0_Q2_USD":250416000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-419980000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":5210000.0,"ProfitLoss_2_Q2_USD":-63888000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":12095000.0,"NetIncomeLoss_2_Q2_USD":-63888000.0,"VariableLeaseCost_2_Q2_USD":102000.0,"Ticker":"KNSA","CIK":"1730430","name":"KINIKSA PHARMACEUTICALS, LTD.","OfficialName":"Kiniksa Pharmaceuticals Ltd. Class A Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"764985918.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200804"}]